where is the best injection site for glp 1 to Inject Ozempic: Stomach, Arm, or Thigh? Where to inject for MAXIMUM

doi: 10.1093/nutrit/nuad042

Female patients make up nearly 65% of GLP-1 users nationwide, and around 5.2% of women with obesity are prescribed a GLP-1 medication (compared to 4.2% of men)

A.TsaiH

Planning for long-term treatment or having a structured taper protocol becomes even more critical in our healthcare system

10.1016/j.cell.2016.05.023 108 WyshamC.BlevinsT.ArakakiR.ColonG.GarciaP.AtissoC.et al (2014)

FDA warning against unapproved GLP-1 drugs for weight loss The official website of FDA clearly states that unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs can be risky for patients